-
Lung cancer trial success boosts Novocure
09 Jan 2023 14:09 GMT
… treated with TTFields and docetaxel versus docetaxel alone," the … for 85% of all lung cancer cases. It is estimated … platinum-resistant non-small cell lung cancer was six years ago, … of lung cancer patients around the world. In China, lung cancer is …
-
Overweight and Obesity are Associated with Poorer Survival Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemotherapy
06 Jan 2023 12:27 GMT
… with advanced lung cancer, particularly those … lung cancer: frequency, diagnostic characteristics, and survival. Transl Lung Cancer … of resected lung cancer independently of … docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer …
-
Addition of tumor treating fields to standard therapy extends OS in advanced lung cancer
06 Jan 2023 04:51 GMT
… IV non-small cell lung cancer.
Researchers reported a trend … with non-small cell lung cancer, according to the therapy … immune checkpoint inhibitors or docetaxel.
Results showed a statistically … platinum-resistant non-small cell lung cancer was 6 years ago, …
-
Novocure Stock Surges As Tumor Treating Fields Shows Overall Survival In Lung Cancer Patients
05 Jan 2023 16:11 GMT
… stage 4 non-small cell lung cancer (NSCLC) following progression while on … were treated with TTFields and docetaxel versus docetaxel alone.
TTFields therapy was …
-
Inspirna Announces Interim Data from Phase 1b/2 Study of Abequolixron (RGX-104) in Relapsed or Refractory Lung Cancer
05 Jan 2023 13:47 GMT
… small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC).
… combination with full dose docetaxel, while showing encouraging … heavily-pretreated patients with lung cancer,” said Hossein Borghaei … advanced or metastatic lung cancer or endometrial cancer. …
-
Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
05 Jan 2023 12:38 GMT
… with TTFields and docetaxel versus docetaxel alone. Patient … with TTFields plus docetaxel versus docetaxel alone (docetaxel cohort). TTFields … Non-Small Cell Lung Cancer
Lung cancer is the most common … approximately 85% of all lung cancers. It is estimated …
-
Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
05 Jan 2023 12:34 GMT
… with TTFields and docetaxel versus docetaxel alone. Patient … lung cancer patients around the world. In China, lung cancer … TTFields plus docetaxel versus docetaxel alone (docetaxel cohort). TTFields … -Small Cell Lung Cancer in China
Lung cancer is the most …
-
Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer
03 Jan 2023 21:05 GMT
… small cell lung cancer (NSCLC, 80%) and small cell lung cancer (SCLC … docetaxel in patients with previously treated non-small-cell lung cancer … Immune oncology biomarkers in lung cancer: an overview. Curr … non-small cell lung cancer treated with palliative …
-
Lung Cancer Therapeutics Market is registering a CAGR of 10.41% and is Expected to Reach USD 54,475.11 Million by 2029
15 Dec 2022 18:15 GMT
… lung cancer are three different types of lung cancer. Global lung cancer … gemzar, taxotere and tarceva … lung-cancer-therapeutics-market
Cancer Type
Non-Small Cell Lung Cancer
Metastatic Lung Cancer … cell lung cancer, metastatic lung cancer, …
-
The Path to Personalized Treatment in KRAS-Mutant Non-Small Cell Lung Cancer: A Review of Targeted Therapies and Immunotherapy
16 Dec 2022 05:17 GMT
… of KRAS-mutant lung cancers exhibit different sensitivity … advanced non–small cell lung cancer (NSCLC) harboring KRASG12C … patients with advanced lung cancer and oncogenic driver … versus docetaxel in advanced nonsquamous non-small-cell lung cancer. …
About
© 1995-2023